// App-Quantinova.ai

OP0066 : EFFICACY OF RITUXIMAB IN SYSTEMIC MANIFESTATIONS OF PATIENTS WITH PRIMARY Sjogren's Syndrome: RESULTS FROM THE AIR REGISTRY

Researchers

Presenter

  • G. Cinquetti

Principal Investigators

  • C. Larroche

  • B. Combe

  • E. Hachulla

  • O. MEYER

  • E. Pertuiset

  • G. Kaplanski

  • X. Mariette

  • J.E. Gottenberg

Medical Centers

  • Hopital Hautepierre, Strasbourg, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Sjogren's syndrome

  • Pancreatitis

  • Solid malignancies

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Methotrexate

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved